Kintara Therapeutics Common Stock

Kintara Therapeutics (KTRA) currently reports a common stock of $64K as of March 2026. That compares with $44K in the prior-year period — up 45.6% year over year. Use the charts on this page to explore Kintara Therapeutics's common stock history and peer comparisons.

Kintara Therapeutics's common stock increased from $44K to $64K — a 45.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kintara Therapeutics reported $64K in common stock as of March 2026. That compares with $44K in the prior-year period — up 45.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $64K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kintara Therapeutics, and consider following KTRA for alerts when major investors trade the stock.

Kintara Therapeutics is classified in the Materials sector. On common stock, it currently shows $64K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing KTRA with unrelated industries.